Product Information

RIZATRIPTAN 10 MG ODT is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5103 per EA under NDC 65862062690. Its NADAC has been published 627 times since Aug 20, 2014.

FDA first approved this application on Jul 1, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIZATRIPTAN 10 MG ODT

Rizatriptan Benzoate
$0.5103per EA

Strength

10 mg/1

NDC

65862062690

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

RIZATRIPTAN BENZOATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203062

FDA Approved

7/1/2013

TE Code

AB

On Market Since

7/1/2013

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for RIZATRIPTAN 10 MG ODT has been published 627 times since Aug 20, 2014, and over the history we have for it it has declined 68.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5103 per EA
All-time high$1.6946 (Apr 13, 2016)
All-time low$0.4145 (Nov 20, 2024)
52-week high$0.5835
52-week low$0.5103
Median price$1.0192
Average price$0.9844
Largest weekly change-31.5% (Nov 20, 2024)
Weeks tracked627
Tracking sinceAug 20, 2014

Price History

1W

-0.7%

1M

-0.7%

3M

-4.5%

6M

-3.4%

1Y

-12.5%

3Y

-21.3%

5Y

-44.8%

All

-68.0%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RIZATRIPTAN 10 MG ODT?

The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 10 MG ODT, manufactured by Aurobindo Pharma Limited, is $0.5103 per EA (NDC 65862062690), effective Aug 19, 2026.

How has the price of RIZATRIPTAN 10 MG ODT changed over time?

Over the history we have for it, the NADAC for RIZATRIPTAN 10 MG ODT has declined 68.0%. It has been tracked across 627 weekly CMS publications since Aug 20, 2014.

What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 10 MG ODT?

Since Aug 20, 2014, the NADAC for RIZATRIPTAN 10 MG ODT has ranged from a low of $0.4145 (Nov 20, 2024) to a high of $1.6946 (Apr 13, 2016), with a median of $1.0192 per EA.

Are there cheaper alternatives to RIZATRIPTAN 10 MG ODT?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 10 MG TABLET, is $0.3204 per EA — about 37% below RIZATRIPTAN 10 MG ODT.

Who manufactures RIZATRIPTAN 10 MG ODT?

RIZATRIPTAN 10 MG ODT (NDC 65862062690) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.